NUSSBAUM RAN purchased 242.9% of their position (1M shares) of LB PHARMACEUTICALS INC on the open market
Open‑market purchase worth $15.00M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/16/2025ACC: 0001609805-25-000006
Director10% Owner
Since Sep 2025
-8.59M
Net shares
Net seller
$15.00M
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
1.41M acquired · 10M disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+411.68K
Price / share
—
Trade value
—
% of position
New position
9/12/2025
0.00→411.68K
Common Stock
Indirect
Shares
+1M
Price / share
$15.00
Trade value
$15M
% of position
242.9%
9/12/2025
411.68K→1.41M
Total
Net shares
+1.41M
Net value
$15M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/12/2025 | C · Conversion | +411.68K | — | — | New position | 0.00 | 411.68K |
| Common Stock Indirect | 9/12/2025 | P · Purchase | +1M | $15.00 | $15M | 242.9% | 411.68K | 1.41M |
| Total | +1.41M | $15M | ||||||
Derivative Transactions1
Series C Preferred Stock
Indirect
Converts to
Common Stock
411.68K shares
Shares
−10M
Strike price
Held after
0.00
Exercisable
—
9/12/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series C Preferred Stock Indirect | Common Stock411.68K shares | 9/12/2025 | C · Conversion | −10M | — | 0.00 |